Dana-Farber Cancer Institute at Boston Medical Center - Brighton — Brighton, Massachusetts

Dana-Farber Cancer Institute at Boston Medical Center - Brighton is a clinical research site located in Brighton, Massachusetts, United States 02135.

Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute at Boston Medical Center - Brighton has participated in 18 clinical trials with 17 currently active.

Therapeutic areas: Light Chain Deposition Disease, Smoldering Multiple Myeloma, Breast Ductal Carcinoma In Situ.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Brighton

Browse all research sites in Massachusetts · View every site in Brighton

• Franciscan Hospital For Children, Inc.
• St. Elizabeth's Hospital
• Franciscan Children's Hospital
• Caritas St. Elizabeth's Hospital
• Metro Boston Clinical Partners
• St Elizabeth's Medical Center
• Steward Saint Elizabeth's Medical Center
• Caritas St. Elizabeth's Medical Center
• MetroBoston Clinical Partners
• Steward St. Elizabeth's Medical Center
• Pfizer Investigational Site

Sponsor Feasibility Report

Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute at Boston Medical Center - Brighton?

Dana-Farber Cancer Institute at Boston Medical Center - Brighton has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute at Boston Medical Center - Brighton conducted?

Dana-Farber Cancer Institute at Boston Medical Center - Brighton has 18 clinical trials on record, with 17 currently active. Their work covers Light Chain Deposition Disease, Smoldering Multiple Myeloma, Breast Ductal Carcinoma In Situ.

Is Dana-Farber Cancer Institute at Boston Medical Center - Brighton accredited by Crixeo Clinical Trials?

Dana-Farber Cancer Institute at Boston Medical Center - Brighton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute at Boston Medical Center - Brighton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.